Travere Therapeutics Inc. (TVTX)
NASDAQ: TVTX
· Real-Time Price · USD
18.76
0.53 (2.91%)
At close: Aug 15, 2025, 12:49 PM
Travere Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 114.45M | 81.73M | 74.79M | 62.9M | 54.12M | 41.37M | 45.06M | 37.09M | 59.7M | 56.99M | 55.87M | 53.5M | 54.17M | 48.49M | 57.25M | 68.22M | 54.62M | 47.41M |
Cost of Revenue | n/a | 4.68M | 2.55M | 1.63M | 12.41M | 1.5M | 16.42M | 1.29M | 1.99M | 5.13M | 1.73M | 1.68M | 2.05M | 2.14M | 1.9M | 1.59M | 1.65M | 1.65M |
Gross Profit | 98.91M | 77.05M | 72.23M | 61.27M | 41.71M | 39.87M | 28.64M | 35.81M | 57.71M | 51.87M | 54.14M | 51.82M | 52.12M | 46.35M | 55.35M | 66.63M | 52.97M | 45.76M |
Operating Income | -12.76M | -41.23M | -60.74M | -54.75M | -67.05M | -139.24M | -82.84M | -89.24M | -87.58M | -80.29M | -69.01M | -64.95M | -65.45M | -57.05M | -47.19M | -31.71M | -35.31M | -47.55M |
Interest Income | 3.29M | 3.79M | 3.79M | 3.57M | 4.42M | 6.03M | 7.15M | 5.84M | 5.13M | 3.65M | 3.12M | 2.1M | 782K | 278K | 236K | 360K | 988K | 409K |
Pretax Income | -12.73M | -41.19M | -60.34M | -54.84M | -69.57M | -135.77M | -88.53M | -89.23M | -85.56M | -86.25M | -65.76M | -69.51M | -66.98M | -75.92M | -51.57M | -35.6M | -38.96M | -53.55M |
Net Income | -12.76M | -41.23M | -60.26M | -54.81M | -70.41M | -136.06M | -90.17M | 150.74M | -85.63M | -86.33M | -65.82M | -69.66M | -67.03M | -75.97M | -51.57M | -35.64M | -39.01M | -53.87M |
Selling & General & Admin | 76.22M | 72.84M | 69.5M | 65.62M | 54.43M | 64.22M | 52.73M | 67.8M | 74.04M | 72.25M | 62.92M | 57.52M | 52.98M | 46.79M | 42.08M | 36.06M | 34.97M | 36.78M |
Research & Development | 49.36M | 46.89M | 62.07M | 51.68M | 54.33M | 114.63M | 58.75M | 60.59M | 69.41M | 59.91M | 60.23M | 59.26M | 59.68M | 56.61M | 62.17M | 48.41M | 51.81M | 47.95M |
Other Expenses | 1.52M | n/a | n/a | 123K | n/a | 238K | n/a | 1.29M | -201K | 87K | 872K | -586K | 662K | 26K | 454K | 654K | 216K | n/a |
Operating Expenses | 127.1M | 119.73M | 132.97M | 117.42M | 108.76M | 178.85M | 111.48M | 129.68M | 143.45M | 132.16M | 123.15M | 116.78M | 112.66M | 103.4M | 104.24M | 84.47M | 86.77M | 84.72M |
Interest Expense | -2.85M | 2.86M | 2.82M | 2.78M | 2.79M | 2.8M | 2.82M | 2.82M | 2.84M | 2.85M | 2.9M | 2.83M | 2.97M | 2.52M | 5.07M | 4.9M | 4.85M | 5.32M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -10.35M | n/a | -10.86M | n/a | n/a | 6.29M | n/a | 5.1M | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 124.41M | 135.52M | 118.92M | 121.17M | 180.35M | 127.9M | 129.68M | 145.44M | 137.28M | 124.88M | 118.45M | 114.71M | 105.54M | 106.14M | 86.06M | 88.42M | 86.37M |
Income Tax Expense | -20K | 39K | -72K | -84K | 85K | 191K | 68K | -12K | 65K | 78K | 63K | 145K | 53K | 52K | 4K | 43K | 49K | 313K |
Shares Outstanding (Basic) | 88.95M | 88.36M | 83.11M | 77.78M | 77.5M | 77.14M | 76.47M | 76.31M | 76M | 68.17M | 64.21M | 64.03M | 63.64M | 63.13M | 61.62M | 60.41M | 60.57M | 56.27M |
Shares Outstanding (Diluted) | 88.95M | 88.36M | 83.11M | 77.78M | 77.5M | 77.14M | 76.47M | 76.31M | 76M | 68.17M | 64.21M | 64.03M | 63.64M | 63.13M | 61.62M | 60.8M | 60.57M | 56.27M |
EPS (Basic) | -0.14 | -0.47 | -0.73 | -0.7 | -0.91 | -1.76 | -1.18 | -0.99 | -1.13 | -1.27 | -1.03 | -1.09 | -1.05 | -1.2 | -0.84 | -0.59 | -0.64 | -0.96 |
EPS (Diluted) | -0.14 | -0.47 | -0.73 | -0.7 | -0.91 | -1.76 | -1.18 | -0.99 | -1.13 | -1.27 | -1.03 | -1.09 | -1.05 | -1.2 | -0.84 | -0.59 | -0.64 | -0.96 |
EBITDA | -12.76M | -25.53M | -45.43M | -40.82M | -56.43M | -123.09M | -73.86M | -74.93M | -93M | -90.75M | -53.56M | -74.03M | -55.9M | -66.31M | -39.44M | -22.82M | -27.49M | -42.16M |
EBIT | -12.65M | -38.33M | -57.52M | -52.06M | -66.78M | -132.97M | -85.71M | -86.41M | -99.02M | -93.64M | -62.86M | -81.09M | -64.01M | -73.4M | -46.5M | -30.7M | -34.11M | -48.23M |
Depreciation & Amortization | n/a | 12.8M | 12.09M | 11.24M | 10.35M | 9.88M | 11.85M | 11.47M | 13.9M | 9.54M | 9.3M | 8.58M | 8.11M | 7.09M | 7.06M | 7.87M | 6.62M | 6.07M |